Jazz Pharmaceuticals PLC (JAZZ)
111.60
+2.06
(+1.88%)
USD |
NASDAQ |
Jul 26, 16:00
111.60
0.00 (0.00%)
After-Hours: 20:00
Jazz Pharmaceuticals Enterprise Value: 10.80B for July 25, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| July 25, 2024 | 10.80B |
| July 24, 2024 | 10.75B |
| July 23, 2024 | 10.73B |
| July 22, 2024 | 10.81B |
| July 19, 2024 | 10.77B |
| July 18, 2024 | 10.76B |
| July 17, 2024 | 10.70B |
| July 16, 2024 | 10.58B |
| July 15, 2024 | 10.41B |
| July 12, 2024 | 10.55B |
| July 11, 2024 | 10.58B |
| July 10, 2024 | 10.34B |
| July 09, 2024 | 10.23B |
| July 08, 2024 | 10.24B |
| July 05, 2024 | 10.28B |
| July 03, 2024 | 10.42B |
| July 02, 2024 | 10.52B |
| July 01, 2024 | 10.61B |
| June 28, 2024 | 10.62B |
| June 27, 2024 | 10.65B |
| June 26, 2024 | 10.65B |
| June 25, 2024 | 10.71B |
| June 24, 2024 | 10.82B |
| June 21, 2024 | 10.70B |
| June 20, 2024 | 10.66B |
| Date | Value |
|---|---|
| June 18, 2024 | 11.00B |
| June 17, 2024 | 11.11B |
| June 14, 2024 | 11.01B |
| June 13, 2024 | 11.00B |
| June 12, 2024 | 10.89B |
| June 11, 2024 | 10.86B |
| June 10, 2024 | 10.77B |
| June 07, 2024 | 10.96B |
| June 06, 2024 | 10.60B |
| June 05, 2024 | 10.61B |
| June 04, 2024 | 10.48B |
| June 03, 2024 | 10.56B |
| May 31, 2024 | 10.53B |
| May 30, 2024 | 10.54B |
| May 29, 2024 | 10.47B |
| May 28, 2024 | 10.52B |
| May 24, 2024 | 10.58B |
| May 23, 2024 | 10.44B |
| May 22, 2024 | 10.54B |
| May 21, 2024 | 10.64B |
| May 20, 2024 | 10.74B |
| May 17, 2024 | 10.76B |
| May 16, 2024 | 10.86B |
| May 15, 2024 | 10.81B |
| May 14, 2024 | 10.95B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
5.455B
Minimum
Mar 23 2020
17.14B
Maximum
Jul 12 2021
11.42B
Average
11.79B
Median
Dec 06 2023
Enterprise Value Benchmarks
| Medtronic PLC | 117.77B |
| Alkermes PLC | 4.029B |
| Perrigo Co PLC | 7.241B |
| Trinity Biotech PLC | 96.16M |
| Iterum Therapeutics PLC | 22.57M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -14.62M |
| Revenue (Quarterly) | 901.98M |
| Total Expenses (Quarterly) | 825.78M |
| EPS Diluted (Quarterly) | -0.23 |
| Gross Profit Margin (Quarterly) | 89.41% |
| Profit Margin (Quarterly) | -1.62% |
| Earnings Yield | 4.35% |
| Operating Earnings Yield | 7.07% |
| Normalized Earnings Yield | 4.603 |